Kouji Joko - Concepedia

Author

Kouji Joko

Matsuyama Red Cross Hospital ORCID

Also Known As

Joko, K., K JOKO, K Joko, K. Joko, K., Joko, KOUJI JOKO, Kouji Joko, Kyoko Joko, M Abe

140

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Matsuyama Red Cross Hospital Ehime Prefectural Central Hospital Ehime University Kagawa Prefectural Central Hospital Okayama Prefecture

About

Kouji Joko is an author at Matsuyama Red Cross Hospital specializing in medicine, hepatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	396
2	Health Sciences	4	4	104
3	Public Health	1	1	32
4	Allergy	1	1	22
5	Diagnostic Sciences	1	1	18

Kouji Joko

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji, Liver Cancer	2018	230
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Liver Cancer	2017	208
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, Cancer Medicine	2019	158
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, Cancer Medicine	2018	130
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima, ESMO Open	2022	124
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients Masahiko Koda, Yoshikazu Murawaki, Yasuaki Hirooka, Hepatology Research	2012	115
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Liver International	2020	95
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, Hepatology Research	2018	94
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, Oncology	2019	83
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice Takaaki Tanaka, Atsushi Hiraoka, Toshifumi Tada, Hepatology Research	2022	77

Page 1